GALNT15
Polypeptide N-acetylgalactosaminyltransferase 15
Also known as: GALNT7, GALNTL2, GLT15_HUMAN, pp-GalNAc-T15
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N3T1
- Gene
- GALNT15
- Ensembl
- ENSG00000131386
- Chromosome
- 3
- Canonical length
- 639 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Golgi apparatus,Cytosol
OverviewNCBI Gene
Predicted to enable polypeptide N-acetylgalactosaminyltransferase activity. Predicted to be involved in protein O-linked glycosylation. Located in transport vesicle. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
639 residues, UniProt reviewed canonical sequence.
>Q8N3T1|GALNT15
1 MLLRKRYRHR PCRLQFLLLL LMLGCVLMMV AMLHPPHHTL HQTVTAQASK HSPEARYRLD
61 FGESQDWVLE AEDEGEEYSP LEGLPPFISL REDQLLVAVA LPQARRNQSQ GRRGGSYRLI
121 KQPRRQDKEA PKRDWGADED GEVSEEEELT PFSLDPRGLQ EALSARIPLQ RALPEVRHPL
181 CLQQHPQDSL PTASVILCFH DEAWSTLLRT VHSILDTVPR AFLKEIILVD DLSQQGQLKS
241 ALSEYVARLE GVKLLRSNKR LGAIRARMLG ATRATGDVLV FMDAHCECHP GWLEPLLSRI
301 AGDRSRVVSP VIDVIDWKTF QYYPSKDLQR GVLDWKLDFH WEPLPEHVRK ALQSPISPIR
361 SPVVPGEVVA MDRHYFQNTG AYDSLMSLRG GENLELSFKA WLCGGSVEIL PCSRVGHIYQ
421 NQDSHSPLDQ EATLRNRVRI AETWLGSFKE TFYKHSPEAF SLSKAEKPDC MERLQLQRRL
481 GCRTFHWFLA NVYPELYPSE PRPSFSGKLH NTGLGLCADC QAEGDILGCP MVLAPCSDSR
541 QQQYLQHTSR KEIHFGSPQH LCFAVRQEQV ILQNCTEEGL AIHQQHWDFQ ENGMIVHILS
601 GKCMEAVVQE NNKDLYLRPC DGKARQQWRF DQINAVDERLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GALNT15 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 132 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 132 nTPM
- spinal cord: 77 nTPM
- breast: 74 nTPM
- blood vessel: 56 nTPM
- midbrain: 36 nTPM
- skin: 34 nTPM
Single-cell type
- fibroblasts: 301 nCPM
- medullary thymic epithelial cells: 166 nCPM
- vascular endothelial cells: 136 nCPM
- myosatellite cells: 112 nCPM
- salivary myoepithelial cells: 107 nCPM
- fibro-adipogenic progenitors: 102 nCPM
Immune cell
- basophil: 0.4 nTPM
- gdT-cell: 0.2 nTPM
- naive B-cell: 0.2 nTPM
- naive CD8 T-cell: 0.2 nTPM
- NK-cell: 0.2 nTPM
- plasmacytoid DC: 0.2 nTPM
Brain region
- medulla oblongata: 325 nTPM
- white matter: 316 nTPM
- pons: 257 nTPM
- spinal cord: 245 nTPM
- hypothalamus: 220 nTPM
- thalamus: 160 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.28
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.23
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GALNT15 as an antibody target. Whether an autoantibody or antibody against GALNT15 could matter depends on whether native GALNT15 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GALNT15 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GALNT15 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...